INTRODUCTION {#s1}
============

Our ability to perceive the world around us and to represent visual information accurately requires correctly mapped innervation of the primary visual centres in the brain by retinal ganglion cell (RGC) axons. Map formation depends on the acquisition of specific positional identities by RGC precursors, as this information underlies the ability of RGC axons to connect appropriately within central targets ([@DEV125120C21]; [@DEV125120C53]). The allocation of nasotemporal (NT) and dorsoventral (DV) positional identities in the eye primordium is already apparent at the optic vesicle stage, long before the first RGCs differentiate ([@DEV125120C28]; [@DEV125120C45]). In fish, prospective retinal cells destined to form the nasal retina are initially located dorsally in the evaginating optic vesicle, whereas prospective temporal retina is located ventrally ([Fig. 1](#DEV125120F1){ref-type="fig"}A; [@DEV125120C45]). A topologically similar organisation is probably present in other vertebrates with nasal retina originating next to dorsal telencephalic forebrain and temporal retina next to ventral, hypothalamic forebrain ([@DEV125120C14]).

The earliest known transcriptional determinants of NT identity are Foxg1 and Foxd1, which show complementary patterns of expression in prospective nasal and temporal domains of the eye primordium, respectively ([@DEV125120C28]). By a combination of loss- and gain-of-function approaches, *foxg1* has been shown to control cell proliferation and acquisition of nasal character during retinal patterning in mouse, chick, frog and zebrafish ([@DEV125120C6]; [@DEV125120C27]; [@DEV125120C31]; [@DEV125120C38]; [@DEV125120C45]). Complementarily, *foxd1* promotes acquisition of temporal character ([@DEV125120C10]; [@DEV125120C29]; [@DEV125120C59][@DEV125120C58]).

In zebrafish, genes encoding the Fgf ligands Fgf8, Fgf3 and Fgf24 are expressed in the forebrain and ectoderm dorsal to the evaginating optic vesicles, and collectively they promote *foxg1* expression and nasal identity in the dorsal optic vesicle ([@DEV125120C44]; [@DEV125120C45]). In the absence of Fgf activity, *foxg1* expression is lost, whereas, conversely, *foxg1* expands within the ventral half of the optic vesicle when the Fgf pathway is ectopically activated in this domain. The temporal determinant *foxd1* responds to Fgf activity in the opposite way. However, although *foxd1* expression expands into the dorsal optic vesicle in the absence of Fgfs, ectopic activation of Fgf activity in the ventral optic vesicle does not completely abrogate *foxd1* expression from this domain ([@DEV125120C44]; [@DEV125120C45]). These observations suggest that, in addition to Fgfs, other signals are involved in establishment of NT regionalisation and complementary *foxg1/foxd1* expression domains. In chick, for example, Wnt3a seems to modulate the expression of these genes, although a role for the Wnt pathway in controlling NT patterning has not been clearly demonstrated ([@DEV125120C59]).

*shh* is expressed along the ventral midline of the forebrain in proximity to ventrally positioned, prospective temporal cells within the evaginating optic vesicles ([@DEV125120C3]; see also [Fig. 3](#DEV125120F3){ref-type="fig"}E). Shh is a morphogen and can generate a gradient of activity that confers different cellular identities according to the levels of ligand and the duration of the signal ([@DEV125120C7]). Consequently, prospective temporal retinal cells may be exposed to Shh during the early phases of optic vesicle evagination and this pathway could therefore influence retinal NT patterning, together with Fgfs.

Although a role for Hh signalling in NT patterning has not been studied, this pathway does influence proximodistal (PD) regionalisation of the evaginated optic vesicle into optic stalk- and retina-forming territories ([@DEV125120C20]; [@DEV125120C36]). Absence of Shh signalling is associated with loss of the optic stalk and cyclopia ([@DEV125120C13]; [@DEV125120C36]; [@DEV125120C61]). Conversely, excessive Shh signalling in the distal, prospective retinal portion of the optic vesicle interferes with retinal specification and promotes an expansion of proximal retinal and optic stalk fates ([@DEV125120C9]; [@DEV125120C20]; [@DEV125120C36]; [@DEV125120C42]). Shh is also proposed to control DV regionalisation within the retina by promoting the expression of the ventral retinal determinant Vax2 ([@DEV125120C35]; [@DEV125120C60]).

In this study, we show that Shh activity is required to activate *foxd1* expression and to initiate temporal retinal identity at the onset of optic vesicle evagination in the zebrafish. Conditions in which Hh activity is lost result in the downregulation of *foxd1* expression. Conversely, ectopic Hh activity in the dorsal optic vesicle activates *foxd1* and represses *foxg1* in this domain. The changes in *foxg1/foxd1* expression upon activation of Hh signalling in evaginating optic vesicles result in altered NT retinal regionalisation and, as a consequence, abnormal targeting of retinal axonal projections in the tectum. Together with previous data, our study shows that NT patterning of the prospective retina is initiated in the optic vesicles by the opposing actions of the Fgf and Shh pathways. Although loss of Shh signalling leads to compromised specification of temporal identity and loss of Fgf signalling to compromised nasal identity, optic vesicles in which both pathways are blocked show recovery of *foxd1* expression, indicating that in the absence of Fgf activity the role of Shh in promoting temporal identity is dispensable. Overall, our results suggest that it is the appropriate balance between Shh and Fgf signals that ensures appropriate NT regionalisation in the forming eyes.

RESULTS {#s2}
=======

Abrogation of Hh signalling activity results in loss of temporal optic vesicle identity {#s2a}
---------------------------------------------------------------------------------------

At early stages of eye formation, cells destined to contribute to temporal retina are positioned ventrally as the optic vesicle evaginates from the forebrain ([Fig. 1](#DEV125120F1){ref-type="fig"}A). We hypothesised that signals emanating from ventral midline tissue of the forebrain may impart temporal character to prospective retinal cells. Among such candidate signals are Shh and Twhh (Shhb -- Zebrafish Information Network), both of which are Hh signalling proteins expressed prominently in ventral forebrain tissue adjacent and ventral to the evaginating optic vesicles ([@DEV125120C3]; [@DEV125120C20]). Consequently, we assessed whether the expression of *foxd1*, the earliest known marker of prospective temporal retina is influenced by Hh signalling. Fig. 1.**Lack of Hh signalling results in loss of temporal fate.** (A) Schematic of early (left) and late (right) organisation of nasotemporal (NT) domains in the developing eye. Note that the NT axis, initially aligned with the DV axis of the embryo, rotates and becomes aligned with the AP axis as development proceeds. Red, temporal domain; green, nasal domain; blue, Shh source. (B-M) Dorsal with anterior to the left (B,D,F-H,J) and frontal (C,E,I,K-M) views of forebrain and eyes showing expression of *foxd1* (B,C,F,H,I,L) and *foxg1* (D,E,G,J,K,M) in the genotypes and treated conditions specified in the panels. All embryos were 10-12ss other than those shown in L and M, which were 5ss. (N,O) Schematic representations of the phenotypic outcome of *foxg1/foxd1* expression in wild-type (N) and lack of Shh (O) conditions. Scale bars: 100 µm. Numbers in the bottom-right of each panel indicate the number of embryos with the phenotype shown out of the total number of embryos analysed. n, nasal; t, temporal; t\*, defective temporal domain. Dashed lines outline the forebrain (dorsal views) or the optic vesicles (frontal views).

Abrogation of Hh activity in *smu* mutants (which lack function of the Smoothened Hh co-receptor; [@DEV125120C61]) or in *syu* mutants (which lack Shh function; [@DEV125120C51]) resulted in loss or downregulation, respectively, of *foxd1* expression in the ventral optic vesicle ([Fig. 1](#DEV125120F1){ref-type="fig"}B,F; data not shown). *foxg1* is normally expressed in prospective nasal retina in a spatially complementary pattern to *foxd1* ([Fig. 1](#DEV125120F1){ref-type="fig"}C,E). However, despite the absence of *foxd1* expression, *foxg1* expression did not expand into the ventral region of the optic vesicle in Hh pathway mutants ([Fig. 1](#DEV125120F1){ref-type="fig"}D,G). Together, these results suggest that initiation of temporal retinal identity requires Hh signalling but that acquisition of nasal identity requires more than just the absence of Hh activity.

Temporally controlled modulation of Hh activity using the Smo antagonist cyclopamine ([@DEV125120C12]; [@DEV125120C57]) revealed that signalling is required in a narrow window at the start of optic vesicle evagination to promote *foxd1* expression. Although cyclopamine treatment starting at the 6-somite stage (ss) did not show any effect on *foxd1* expression or temporal fate specification ([Fig. S1A-D](Fig. S1A-D)), treatment from 1-3ss onwards resulted in a complete loss of *foxd1* expression ([Fig. 1](#DEV125120F1){ref-type="fig"}H,I) as well as of the *HGn42A::GFP* transgene ([@DEV125120C45]), which specifically labels the temporal half of the eye primordium ([Fig. S1E,F](Fig. S1E,F)). Expression of the nasal markers *foxg1* and the *-8.0claudinb::lynGFP^zf106^* transgene ([@DEV125120C22]) were not overtly affected by these treatments ([Fig. 1](#DEV125120F1){ref-type="fig"}J,K; [Fig. S1I,J](Fig. S1I,J)), a result consistent with the phenotype observed in *smu* and *syu* mutants. These results indicated that the Hh pathway is required between 1-3 and 6ss to promote temporal specification. At this stage, the optic vesicles are just starting to evaginate, but expression of *foxd1* and *foxg1* is already spatially restricted to complementary domains of the primordium ([Fig. 1](#DEV125120F1){ref-type="fig"}L,M).

Ectopic Hh activity suppresses nasal and expands temporal identity in the optic vesicles {#s2b}
----------------------------------------------------------------------------------------

The results described above indicated that Hh signalling is required to induce temporal identity at an early stage of optic vesicle development. To assess whether Hh activity is sufficient to promote *foxd1* expression and temporal identity, we expressed UAS:*shh* in the early, evaginating optic primordium by use of a Gal4 driver (*Tg{rx3:Gal4}*) expressed in the eye field and evaginating optic vesicles ([@DEV125120C64]). This approach did not interfere with the establishment of primary subdivisions in the forebrain, as revealed by the largely normal telencephalic expression of *foxg1* (compare [Fig. 2](#DEV125120F2){ref-type="fig"}A and 2B) and the optic vesicle and midbrain marker *mab21l2* ([Fig. S2A,B](Fig. S2A,B)). Fig. 2.**Ectopic Hh activity in the optic vesicle promotes temporal fate.** (A-D,G,H) Expression of *foxg1* (A,B) and *foxd1* (C,D,G,H) in the genotypes specified in the panels. (E,F) Retinotectal projections traced with DiI/DiO to label nasal (n; green) and temporal (t; red) projections. Main panels show the tectum with anterior to the left; insets show the corresponding eye. (I,J) Schematic of the phenotypic outcome of *foxg1/foxd1* expression in the conditions shown in the figure. A-D are frontal views; G and H are lateral views of dissected eyes. All embryos are at 10-12ss except those in E-H, which are 6 dpf. Scale bars: 100 µm. Numbers in the bottom-right of each panel indicate the number of embryos with the phenotype shown out of the total number of embryos analysed. n\*, defective nasal domain. Dashed lines outline the optic vesicles (A-D), the tectum (E,F) and the optic cup (insets in E,F).

Expression of Shh throughout the evaginating optic vesicles resulted in expansion of *foxd1* expression and repression of *foxg1* throughout the optic primordia but not in the adjacent telencephalon ([Fig. 2](#DEV125120F2){ref-type="fig"}A-D,I,J). The same effect within the optic vesicle was observed when we mosaically overexpressed Shh in subsets of eye field cells, or when Shh was overexpressed at low levels throughout the whole embryo ([Fig. S3A-D′](Fig. S3A-D′)). Broad overexpression of *ptch2* confirmed that the exogenous Shh in these experiments ectopically activates the Hh pathway ([Fig. S3E,G](Fig. S3E,G)).

The enhanced expression of *foxd1* at the expense of *foxg1* in the presence of excessive Hh signalling suggested an expansion of temporal character in the optic primordium. To assess whether this change is reflected in the NT character of differentiated RGCs, we analysed the topology of retino-tectal projections by lipophilic dye labelling of nasal and temporal axons of wild-type and *Tg{rx3:Gal4}*;UAS:*shh* retinae. Nasal projections in wild-type 6 days post-fertilisation (dpf) fry innervated posterior regions of the tectum and clearly segregated from temporal projections ([Fig. 2](#DEV125120F2){ref-type="fig"}E). By contrast, nasal projections in *Tg{rx3::Gal4}*;UAS:*shh* retinae targeted more anterior regions of the tectum and partially overlapped with projections from the most temporal part of the retina ([Fig. 2](#DEV125120F2){ref-type="fig"}F). This suggests that nasally positioned RGCs acquire temporal identity after early exposure of the optic vesicle to Hh activity. This change of character is consistent with the widespread expansion of *foxd1* in retinal ganglion cells of *Tg{rx3::Gal4}*;UAS:*shh* embryos ([Fig. 2](#DEV125120F2){ref-type="fig"}G,H).

Fgf does not appear to affect levels of Hh signalling whereas Hh activity promotes Fgf signalling {#s2c}
-------------------------------------------------------------------------------------------------

Previous studies have shown that Fgf signalling promotes nasal identity in the optic vesicles; abrogation of Fgf activity results in the loss of nasal identity and the concomitant expansion of temporal fate ([@DEV125120C44]; [@DEV125120C45]). Thus, whereas loss of Fgf activity results in a transformation of nasal into temporal identity, loss of Hh activity instead leads to a loss of temporal character that is not accompanied by acquisition of nasal character. A possible contributory factor to these phenotypes would be cross regulation of Hh and Fgf signalling pathways. Consequently, we analysed expression of *fgf8* and the Fgf pathway target *sprouty4* in Hh loss-of-function embryos, and that of *shh* and the Hh target transgene *ptch2::kaede* ([@DEV125120C30]), after interference with Fgf signalling.

Blocking Fgf signalling with the antagonist SU5402 ([@DEV125120C40]) from 1-2ss onwards efficiently transformed nasal to temporal character in the optic vesicle, as revealed by expanded *foxd1* and loss of *foxg1* expression ([Fig. 3](#DEV125120F3){ref-type="fig"}A-D; [@DEV125120C45]). However, neither the expression of *shh* nor that of the *ptch2::GFP* transgene was affected by this treatment ([Fig. 3](#DEV125120F3){ref-type="fig"}E-H), suggesting that in the absence of Fgf signalling, Hh activity is largely unaffected. Fig. 3.**Lack of Fgf activity alters NT patterning independently of Shh activity.** (A-L) Expression of *foxg1* (A,B), *foxd1* (C,D), *shh* (E,F), Kaede (G,H), *fgf8* (I,J) and *sprouty4* (K,L) in the conditions specified in the panels. A-H are frontal views; I-L are dorsal views with anterior to the left. All embryos are at 10-12ss. Scale bars: 100 µm. Numbers in the bottom-right of each panel indicate the number of embryos with the phenotype shown out of the total number of embryos analysed. n, nasal; t, temporal; n\*, defective nasal domain. Dashed lines outline the forebrain (dorsal views) or the optic vesicles (frontal views).

Conversely, the level of Hh activity does affect Fgf signalling as cyclopamine treatments reduced the levels of both *fgf8* and *sprouty4* expression ([Fig. 3](#DEV125120F3){ref-type="fig"}I-L). This observation may help to explain why in the absence of Shh, nasal identity does not expand because there may be insufficient levels of inducer (Fgf) in the ventral portion of the optic vesicle to activate *foxg1*.

Simultaneous abrogation of Fgf and Hh partially rescues NT patterning {#s2d}
---------------------------------------------------------------------

Our results indicate that Hh activity is necessary and sufficient to promote *foxd1* expression in the optic vesicle. Furthermore, the observation that *foxg1* does not expand when Hh activity is downregulated suggests that nasal and temporal identities might be established independently from each other by Fgf and Hh signals, respectively. If so, one might expect that simultaneous abrogation of Fgf and Hh activity should then lead to the absence of both nasal and temporal character. To test this hypothesis, we simultaneously abrogated Fgfs and Hhs by making use of two different approaches: analysis of double mutants for *fgf8* (*acerebellar*; *ace*) and *smu*; and combined treatment with the pathway antagonists cyclopamine and SU5402.

Contrary to expectation, simultaneous abrogation of Hh and Fgf signals led to a surprising recovery of NT patterning. Thus, whereas cyclopamine treatment alone led to absence of *foxd1* expression ([Fig. 1](#DEV125120F1){ref-type="fig"}H,I), when combined with SU5402, expression of *foxd1* and the *HGn42A::GFP* transgene was restored within the prospective temporal retina ([Fig. 4](#DEV125120F4){ref-type="fig"}A-D; [Fig. S1H](Fig. S1H)). A similar result is observed in *ace*;*smu* double mutants ([Fig. S4D](Fig. S4D),E). This implies that Hh signalling is only needed for induction of temporal character when Fgf signalling is active (and that Fgf activity represses *foxd1* independently of Foxg1). This result cannot be explained by a failure of the drugs to work when in combination as expression of the pathway reporters *ptch2* and *sprouty4* is largely lost following cyclopamine+SU5402 treatments ([Fig. 4](#DEV125120F4){ref-type="fig"}E-H). Thus, simultaneous loss of Hh and Fgf activity compromises NT patterning less than manipulation of just one of these signals, suggesting that NT patterning is influenced by the correct balance of both signals, and not by their absolute levels. Fig. 4.**NT patterning is restored upon combined abrogation of both Fgf and Hh signals.** Expression of *foxg1* (A,B,I,K,L), *foxd1* (C,D,J,M,N), *sprouty4* (E,F) and *ptch2* (G,H) in in the conditions specified in the panels. A-D,I-N are frontal views; E-H are dorsal views with anterior to the left. All are zebrafish embryos at 10-12ss, except for those in K-N, which are cavefish (cf) and surface fish (sf) forms of *Astyanax mexicanus*. Scale bars: 100 µm. Numbers in the bottom-right of each panel indicate the number of embryos with the phenotype shown out of the total number of embryos analysed. Dashed lines outline the forebrain (dorsal views) or the optic vesicles (frontal views).

Similar to the observed restoration of temporal character, there was partial restoration of nasal *foxg1* expression upon abrogation of both Hh and Fgf signals ([Fig. 4](#DEV125120F4){ref-type="fig"}A,B; [Fig. S1L; Fig. S4](Fig. S1L; Fig. S4)), which is more complete in *ace*;*smu* mutants than in fish treated with cyclopamine+SU5402 (compare [Fig. 4](#DEV125120F4){ref-type="fig"}B with [Fig. S4D](Fig. S4D)), as also confirmed by statistical analysis ([Fig. S4A-C](Fig. S4A-C)). This difference is probably due to the fact that in *ace*;*smu* double mutants Fgf abrogation is only partial, as the presence of Fgf3 and Fgf24 still probably activates the Fgf pathway ([@DEV125120C45]). As expression of *foxg1* was not fully restored in the absence of both Fgf and Hh signals, it suggests a more important role for Fgf signals in promoting nasal character than Hh signals in promoting temporal character. This result, together with the fact that *foxg1* does not expand to the temporal retina in the absence of Hh ([Fig. 1](#DEV125120F1){ref-type="fig"}J,K), further reinforces the idea that Hh does not directly repress *foxg1*.

The abrogation of Fgf and Hh activities simultaneously from 1ss resulted, as shown above, in a partial recovery of the NT pattern. This suggests that earlier signalling events might be establishing *foxd1/foxg1* expression. To assess whether even earlier modulation of the Hh and Fgf signalling pathways affects the spatially restricted expression of *foxd1/foxg1* in the optic vesicle, we simultaneously abrogated Fgf and Hh signalling from mid-gastrulation, well before NT patterning is established.

Cyclopamine+SU5402 treatments from mid-gastrulation result in a dramatic expansion of *foxd1* and complete loss of *foxg1* expression within the optic vesicle ([Fig. 4](#DEV125120F4){ref-type="fig"}I,J), a phenotype comparable to that obtained by treatment with SU5402 alone \[treatment from mid-gastrulation with only one drug at a time led to phenotypes very similar to those obtained with treatments at 1ss (not shown)\]. This result supports the idea that Hh activity is fully dispensable for induction of *foxd1* expression in the absence of Fgf signalling. It suggests that Hh signalling prevents repression of *foxd1* by the Fgf signalling pathway, and, in this way, promotes temporal identity.

To further explore cross-regulation between Fgf and Hh pathways, we analysed NT patterning in cavefish (*Astyanax mexicanus*) embryos in which levels of Fgfs and *shh* vary between surface fish and cavefish forms. The species *Astyanax mexicanus* has a surface form, which lives in rivers and lakes, and a cavefish form, which lives in caves. These two populations were isolated from each other ∼10,000 years ago, and since then they have evolved divergently. The cavefish form has undergone a number of morphological changes in the forebrain, which seem to have their origin in subtle changes in expression patterns of regulatory genes during forebrain development ([@DEV125120C46]). One of these changes is an increased level of *shh* and precocious expression of *fgf8* in the forebrain of the cavefish form in comparison to the surface fish form. Thus, cavefish present the opportunity to assess the effect of contemporaneously higher levels of *fgf8* and *shh* on NT patterning of the optic vesicles. We reasoned that if Shh counteracts the repressive activity of Fgfs upon *foxd1* expression, then higher levels of both signals may not compromise NT patterning. Indeed, cavefish optic vesicles show similar levels of *foxg1* and *foxd1* expression compared with surface fish ([Fig. 4](#DEV125120F4){ref-type="fig"}K-N), indicating that concomitant upregulation of the Hh and Fgf pathways does not overtly affect NT patterning. Together, these results support the idea that it is the relative, rather than the absolute, levels of these two signals that influence the establishment of NT identity.

Mutual repression between *foxg1* and *foxd1* maintains the border between nasal and temporal domains {#s2e}
-----------------------------------------------------------------------------------------------------

Our results indicate that Fgf and Hh signals work in concert to promote mutually exclusive expression of *foxg1* and *foxd1* in the nasal and temporal retina, respectively. Previous studies in chick and mouse suggest that *foxd1* and *foxg1* can repress each other. For example, *Foxd1* expression expands into the nasal half of the optic vesicle in *Foxg1* mouse mutants ([@DEV125120C31]), and misexpression of *Foxd1* or *Foxg1* interferes with the expression of the complementary gene in chick ([@DEV125120C59][@DEV125120C58]). To assess whether Foxg1 and Foxd1 cross-repress each other in zebrafish, we manipulated the levels of *foxg1* and *foxd1* in the optic vesicle through use of the Gal4/UAS approach as described above.

Ectopic expression of *foxg1* in the temporal half of the optic vesicle strongly downregulated *foxd1* ([Fig. 5](#DEV125120F5){ref-type="fig"}A,B); conversely, *foxd1* expression in the nasal part of the optic vesicle downregulated *foxg1* expression ([Fig. 5](#DEV125120F5){ref-type="fig"}C,D). Thus, reciprocal repression between *foxg1* and *foxd1* occurs in fish as in other vertebrates. During normal development, the only position at which transcriptional cross-regulatory competition between Foxd1 and Foxg1 is likely to influence *foxg1* and *foxd1* expression is around the NT boundary where cells may receive sufficient Shh and Fgf signals to induce both genes. Fig. 5.**Mutual repression between *foxg1* and *foxd1* maintains the NT border.** (A-D) *foxd1* (A,B) and *foxg1* (C,D) expression in the conditions detailed in the panels. All panels show dorsal views with anterior to the left at 10-12ss. (E) Schematic representation of the regulatory interactions inferred from our manipulations. (F) Representative *Tg (rx3:Gal4)*;* UAS:foxd1* embryo showing widespread GFP expression in the optic vesicles. All embryos selected for *in situ* analysis showed similarly broad GFP expression. Scale bar: 100 µm. Numbers in the bottom-right of each panel indicate the number of embryos with the phenotype shown out of the total number of embryos analysed. Dashed lines outline the forebrain.

DISCUSSION {#s3}
==========

This study uncovers a novel role for Shh in initiating the expression of the temporal fate determinant *foxd1* in the ventral half of the evaginating optic vesicles. Consequently, an interplay between Hh signals and Fgfs, which promote *foxg1* expression in the dorsal, prospective nasal half of the optic vesicle, establishes NT pattern in the nascent optic primordium. Our results indicate that these two signals establish temporal and nasal identity at least in part independently of each other and that, once established, the boundary between nasal and temporal domains is maintained by mutual transcriptional repression between Foxd1 and Foxg1 ([Fig. 6](#DEV125120F6){ref-type="fig"}). Fig. 6.**Opposing roles for Fgfs and Shh in the control of optic vesicle patterning.** (A) Schematics of *foxg1* (green) and *foxd1* (red) expression in optic vesicles following manipulations of Fgf and Hh signals. The implications below are based on the ability of Foxg1 to repress *foxd1* expression and Foxd1 to repress *foxg1* expression. (i) Shh gain of function: loss of *foxg1* and gain of *foxd1* in nasal retina. This implies that Shh signalling promotes *foxd1* expression and/or inhibits *foxg1* expression. Blue shading and dots represent Shh expression. (ii) Shh loss of function: loss of *foxd1* in temporal retina. This implies that Shh promotes *foxd1* expression but is not required for repression of *foxg1*. (iii) Combined loss of Shh and Fgf: loss of *foxg1* and gain of *foxd1* in nasal retina. This implies that either unknown signals (grey arrow in B) promote *foxd1* expression in absence of Shh or that repressors (such as Fgf itself) are removed in this situation. The result also implies that Fgf is required for the repression of *foxd1* in temporal retina (shown in ii), and that this repression is independent of Foxg1 (which is not expressed in temporal retina). (iv) Loss of Fgf expression: loss of *foxg1* and gain of *foxd1* in nasal retina. This implies that Fgf promotes *foxg1* and/or inhibits *foxd1* in nasal retina. (v) Gain of Fgf function: gain of *foxg1* expression and loss of *foxd1* expression in temporal retina (data taken from [@DEV125120C44]; [@DEV125120C45]). This implies that Fgf promotes *foxg1* expression and/or inhibits *foxd1* expression. (B) Proposed regulatory interactions that could explain the retinal nasotemporal phenotypes shown in A, together with data not shown that both Fgf and Shh promote development of *pax2*+ optic stalk identity in the proximal optic vesicle. As stated in the main text, the regulatory interactions leading to nasotemporal patterning occur from neural plate stage onwards. (C,D) Images showing the domains of expression in the forebrain of genes encoding the signals studied (C) and their Fox gene targets (D), as evident from double *in situ* hybridisation assays of 10ss embryos. Dashed lines outline the optic vesicles.

Similarities to, and differences from, other patterning systems involving Fgfs and Shh {#s3a}
--------------------------------------------------------------------------------------

The role for Shh and Fgfs that we describe for NT patterning of the optic vesicle is similar to that for anterior-posterior (AP) patterning of the otic vesicle, the primordium for the vertebrate ear. Fgfs, expressed rostral to the otic vesicle, promote anterior identity, whereas Shh, released by the tissues underlying the ear primordium, induces posterior identity ([@DEV125120C25][@DEV125120C26]; [@DEV125120C24]). Manipulation of the levels of these two pathways affect AP patterning in the otic vesicle in a reciprocal way: loss of Fgf activity results in loss of anterior identity and the development of a double-posterior primordium; conversely, loss of Hh activity results in loss of posterior identity and the development of a partial double-anterior primordium. However, double loss of Hh and Fgfs results in an otic vesicle with neither anterior nor posterior identities, whereas in the optic vesicles NT patterning is partially recovered in such conditions.

Loss of both Shh and Fgf from mid-gastrula stage leads to absence of *foxg1* expression, indicating that Fgf activity from gastrula stages onwards promotes subsequent expression of *foxg1* expression in the prospective nasal retina. In addition, in these conditions *foxd1* expression expands throughout the optic vesicle, reinforcing the idea that Shh is dispensable for *foxd1* expression, provided there is no Fgf activity. Thus, acquisition of temporal identity normally requires the activity of Shh from as early as neural plate stages, to counteract Fgf-dependent repression of *foxd1* expression.

The recovery of *foxd1* expression in the optic vesicle in conditions in which both Fgf and Shh are abrogated is not the only situation in which loss of Hh activity can be compensated by following additional genetic changes. In the spinal cord, graded responses to Shh establish ventral neuronal identities and, consequently, ventral fates are lost upon removal of Shh activity (reviewed by [@DEV125120C16]; [@DEV125120C18]). Ventral identities are, however, largely recovered when the function of the Gli3 transcriptional repressor of Hh target genes is also removed ([@DEV125120C43]). Thus, acquisition of ventral spinal cord cell type identities can occur in a Shh-independent mechanism. This reveals a remarkable robustness in the establishment of DV patterning in the neural tube and NT patterning in the optic vesicle, and suggests the presence of compensatory mechanisms that can bypass requirement for Hh signalling.

A surprising aspect of the retinal NT phenotype following abrogation of both Shh and Fgf is the implication that Fgf is required for repression of *foxd1* expression in the temporal retina independently of Foxg1 (and in addition to the Fgf-dependent repression of *foxd1* in nasal retina that could be mediated through Foxg1; [Fig. 5](#DEV125120F5){ref-type="fig"}A,B). At least at the stages when optic vesicles initiate Fox gene expression, Fgf targets do not appear to be expressed in the prospective temporal domain ([@DEV125120C45]; M.H.-B., F.C., G.G. and S.W.W., unpublished observations). This implies either that the Fgf pathway is activated earlier in this domain, or, if at the stage when Fox genes are induced, at sufficiently low levels so as to not activate expression of *foxg1*. An alternative possibility is that the repression is indirect and dependent upon non-autonomous consequences of Fgf activity in nasal retina. Although again we do not know how this might occur, Gli protein regulation is a likely target for regulation of the Hh pathway given that Gli function can be modulated by other pathways in a variety of other contexts ([@DEV125120C1]).

Despite our results showing limited transcriptional cross-regulation between Shh and Fgf signalling during NT patterning of the optic vesicle, these pathways show many such regulatory interactions in other contexts. For example, Shh promotes *fgf8* expression in the rostral-most tip of the prosencephalon, and Fgf in turn promotes basal telencephalic *Shh* expression in a cross-regulatory interaction that modulates telencephalic patterning ([@DEV125120C2]; [@DEV125120C17]; [@DEV125120C41]; [@DEV125120C54]; [@DEV125120C55]; [@DEV125120C56]; [@DEV125120C63]; this study). Similarly in cavefish, enhanced levels of *shh* expression at neural plate stages is correlated with precocious and stronger expression of *fgf8* in the prospective telencephalon ([@DEV125120C39]; [@DEV125120C46]). In the limb, Shh (expressed in the posterior portion of the primordium, known as the zone of polarising activity) and Fgfs (expressed in the distal portion of the limb primordium, termed the apical ectodermal ridge) engage in a complex regulatory feedback loop essential for allocation of correct proportions to elements in the growing limb (reviewed by [@DEV125120C5]; [@DEV125120C4]; [@DEV125120C52]; [@DEV125120C67]). In the ventral CNS, coordinated Fgf and Shh activities regulate the generation of cell diversity ([@DEV125120C50]). In this context, spatiotemporal coincidence of Shh and Fgf signalling in the caudal neural tube provides temporally constrained competence to initiate floor plate specification. As the neural tube extends, the source of Fgf is distanced from the ventral spinal cord and Shh acts independently to promote ventral neuronal fates.

Fgf and Shh signals pattern both the NT and DV axes of the optic vesicles {#s3b}
-------------------------------------------------------------------------

In addition to roles in NT patterning, the Fgf and Hh signalling pathways are also required for formation of proximal optic stalk fates within the optic vesicle. Both Fgfs and *shh* are expressed in the anterior-most tip of the forebrain, adjacent to the region at which the optic vesicles remain connected to the forebrain through the optic stalks. As previously shown, alterations to either signalling pathway can shift the optic stalk/retina boundary and disrupt optic stalk/nerve differentiation ([@DEV125120C9]; [@DEV125120C13]; [@DEV125120C20]; [@DEV125120C35]; [@DEV125120C36]; [@DEV125120C37]; [@DEV125120C42]; [@DEV125120C60]; [@DEV125120C63]). We propose that the specific outcomes of the activity of these two pathways on the forming eye are the consequence of the differing spatial distributions of signals coupled with temporally regulated receptiveness of optic vesicle cells as they undergo dynamic morphogenetic movements (see model in [Fig. 6](#DEV125120F6){ref-type="fig"}; [@DEV125120C45]). Indeed, *shh* and Fgfs are expressed in adjacent domains at the anterior-most region of the forebrain, and thus the anterior-most region of the evaginating optic vesicles -- the presumptive optic stalk -- is probably exposed to both signals. More posteriorly, as optic vesicle cells evaginate into the prospective temporal retina, they are probably exposed to Hh signals alone whereas as they ingress into the prospective nasal retina they are exposed to Fgf signals.

Eye field cells extensively intercalate among each other as they incorporate in the evaginating primordia ([@DEV125120C32]). We have speculated that this mixing means that it is not possible to predict the final fate of many cells within the eye field and, consequently, we have proposed that regional fate would only be established after cells have evaginated into the optic vesicles. The results shown in this study show that signals influencing NT patterning are acting from very early stages, probably prior to completion of the integration of eye field cells into the optic vesicles. However, the signals required to establish NT pattern are produced and secreted by dorsal and ventral forebrain territories with organiser-like properties ([@DEV125120C45]). These territories constitute 'fixed' domains relative to the eye field/optic vesicle, and exert their influence upon cells entering either the dorsal or the ventral half of the eye primordium, irrespective of their original location within the eye field prior to evagination. This mechanism of fixing the sources of signals could provide robustness to patterning in morphogenetic contexts where cells are undergoing dynamic reorganisations.

Generating sharp boundaries downstream of morphogenetic signals {#s3c}
---------------------------------------------------------------

In the spinal cord, Shh controls the expression of transcription factors that collectively subdivide the neural tube into discrete generative domains along its DV axis (reviewed by [@DEV125120C18]). Shh-regulated transcription factor-encoding genes expressed in adjacent domains are frequently cross-repressive. This has the consequence that any individual cell (usually at a boundary between domains) would resolve its expression to one or other of the mutually repressive genes, thereby sharpening the boundary between domains ([@DEV125120C15]). The scenario we describe in the optic vesicle is highly reminiscent of this mode of patterning. Shh initiates expression of *foxd1*, and then Foxd1 represses *foxg1*, which is induced by Fgfs and, in turn, Foxg1 can repress *foxd1*. This cross-repression would then ensure that the cells at the NT boundary would only adopt either nasal or temporal identity. In this way, the early graded activity of Shh and Fgf could be translated into the establishment of a sharp NT border that is maintained throughout later stages of eye development.

MATERIALS AND METHODS {#s4}
=====================

Fish lines and husbandry {#s4a}
------------------------

*AB* and *tupl* wild-type zebrafish strains, and transgenic lines *Tg{rx3::GFP}^ET95/1^* ([@DEV125120C8]; [@DEV125120C47]), *Tg{emx3::YFP}^b1200^* ([@DEV125120C62]), *Tg{rx3::Gal4-VP16}^vu271Tg^* ([@DEV125120C64]), *Tg{ptch2::kaede}^a4596Tg^* ([@DEV125120C30]), *Tg{-8.0claudinb::lynGFP}^zf106^* ([@DEV125120C22]) and *Tg{HGn42A::GFP}^nkhgn42aEt^* ([@DEV125120C45]) were maintained and bred according to standard procedures ([@DEV125120C65]). Laboratory stocks of *A. mexicanus* surface fish and cavefish (Pachón population) were obtained from the Yamamoto laboratory at UCL. All experiments conform to the guidelines from the European Community Directive and the British and Spanish legislation for the experimental use of animals.

Microinjection and drug treatments {#s4b}
----------------------------------

*shh*, *foxd1* and *foxg1* were expressed in the optic vesicles using the UAS/Gal4 system ([@DEV125120C23]). UAS constructs were generated by subcloning the test cDNA into a bidirectional UAS/tol2 plasmid, which drives GFP transcription in one direction and the test cDNA transcription in the other ([@DEV125120C19]; [@DEV125120C33]). UAS constructs were injected into one-cell-stage *Tg{rx3::Gal4}* embryos (at 20-40 pg/embryo) and the embryos showing homogeneous GFP expression in the eye primordia were selected for further analysis. *shh* mRNA for microinjection was synthesised using the mMessage Machine kit (Ambion), following the manufacturer\'s instructions.

Drug treatments were performed by incubating dechorionated embryos in E3 medium with cyclopamine (100 μM, Calbiochem), SU5402 (10 μM, Calbiochem) or a combination of both. As stocks of cyclopamine and SU5402 were kept in DMSO, controls for these treatments were incubated in the same amount of E3 medium with the equivalent concentration of DMSO. The treatment was stopped at 10/12ss and the embryos were washed and fixed for further analysis. Note that in our experimental conditions, Shh/Fgf abrogations are performed once the first stages of forebrain patterning have taken place, and thus are unlikely to promote changes in primary forebrain subdivisions, as revealed by the normal expression of optic vesicle and telencephalic markers ([Fig. S2C-H](Fig. S2C-H); see also [@DEV125120C48]; [@DEV125120C55]).

mRNA detection and immunolabelling {#s4c}
----------------------------------

Antisense mRNA probes for whole-mount *in situ* hybridisation were synthesised using RNA polymerases (Promega) and digoxigenin- or fluorescein-labelled nucleotides (Roche), following the manufacturer\'s instructions. Whole-mount *in situ* hybridisations were performed essentially as previously described ([@DEV125120C11]; [@DEV125120C66]). For visualisation, embryos were incubated with anti-digoxigenin/fluorescein-AP and developed using NBT/BCIP substrates (Roche). For fluorescent detection, embryos were incubated with anti-digoxigenin-POD (Roche) and developed using Cy3-TSA (Perkin Elmer) as a substrate. Immunolabelling was performed as previously described ([@DEV125120C11]) with the following antibodies: chicken anti-GFP (Abcam, cat. no. ab13970; 1:1000); mouse anti-βcatenin (Signal Transduction Laboratories, cat no. 610154; 1:400) and Alexa-488 and -647 coupled secondary antibodies (Jackson ImmunoResearch, 1:500). Sytox Orange (Life Technologies, 1:10,000) was used to counterstain nuclei.

Tracing of retinotectal projections {#s4d}
-----------------------------------

DiI and DiO were used to label nasal and temporal retinal ganglion cells at 6 dpf in paraformaldehyde-fixed wild-type and *Tg{rx3::Gal4}*; UAS:*Shh* retinae. Fry were incubated at room temperature for 24 h before preparing them for imaging. Each tectum and its corresponding eye were sequentially imaged.

Imaging and data processing {#s4e}
---------------------------

DiI/DiO-traced embryos and *Tg{ptch2::kaede}^a4596Tg^* embryos were embedded in low melting point agarose (Sigma) at 1-1.5% in PBS for confocal imaging using a 40× (0.8NA) long-working distance water immersion lens. A Zeiss LSM710 confocal microscopy system was used for image acquisition.

*In situ* hybridised embryos were mounted flat in a drop of glycerol and dorsal images were acquired with a 20× (0.70NA) dry lens using a Leica CTR 5000 microscope connected to a digital camera (Leica DFC 500), and operated by Leica software. Some of these embryos were embedded in gelatine/BSA for vibratome sectioning as previously described ([@DEV125120C49]). Sections (20 μm thick) were obtained using a Leica VT1000S vibratome, mounted in glycerol, and imaged with a 40× (0.85NA) dry lens.

Raw confocal data were analysed with Fiji/ImageJ. Images were exported as TIFF files and all figures were composed using Photoshop.
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